My watch list
my.bionity.com  
Login  

Rare Diseases

News Rare Diseases

  • A cautionary tale on genome-sequencing diagnostics for rare diseases

    Children born with rare, inherited conditions known as Congenital Disorders of Glycosylation, or CDG, have mutations in one of the many enzymes the body uses to decorate its proteins and cells with sugars. Properly diagnosing a child with CDG and pinpointing the exact sugar gene that's mutated can b more

  • European Medicines Agency publishes 2012 annual report

    The European Medicines Agency has published its 2012 annual report. The report highlights the main trends recently observed in the Agency’s activities. For the past few years, the Agency has received a stable number of initial marketing authorisation applications (MAAs) for human medicines, with a t more

  • Prosensa receives rare disease 'Company Award' from EURORDIS

    Prosensa received the ‘Company Award’ at the EURORDIS Black Pearl Gala Dinner in Brussels. The Black Pearl Gala Dinner is hosted annually by EURORDIS, a non-governmental alliance of patients and patient organizations active in the field of rare diseases, to celebrate Rare Disease Day. Awards recogni more

All news on rare diseases

White papers Rare Diseases

Publications Rare Diseases

All publications on rare diseases

Market studies Rare Diseases

  • Afinitor - A Two-Pronged Attack Against Tuberous Sclerosis Complex

    Introduction GlobalData’s new alert, "Afinitor - A Two-Pronged Attack Against Tuberous Sclerosis Complex”, takes a look at the implications of the FDA’s recent approval of the drug for the treatment of angiomyolipomas, benign kidney tumors that affect a majority of people with this rare disease. more

  • United Kingdom Pharmaceuticals and Healthcare Report Q4 2012

    BMI View: We retain our broadly pessimistic outlook for the UK’s pharmaceutical market over the five years to 2016, although the emphasis on cost containment will serve to boost the performance of the generic drug sector. A difficult economic situation will also prioritise economically priced items more

  • Israel Pharmaceuticals and Healthcare Report Q2 2012

    BMI View: Following widespread protests in mid-2011, the Israeli government has been under significant pressure to spend more on housing, healthcare and education. While it was not about to tear down the country's privatised healthcare system, it has been able to support it by subsidising sick funds more

All market studies on rare diseases

Websites Rare Diseases

Enobia Pharma - Homepage

X Enobia Homepage Home | Search | Contact | Français Hypophosphatasia Key Discoveries in the History of HPP Clinical Presentation Diagnosis Pathophysiology Epidemiology Managing HPP Science ENB-0040 Pipeline Glossary Patients About Hypophosphatasia Diagnosing Hypophosphatasia Treating Hypophosphatas more

Alexion Pharmaceuticals - Alexion Pharmaceuticals | Innovators in Complement Inhibition

Alexion Pharmaceuticals Contact Us Legal Sitemap About Us Soliris & PNH R & D Investors Careers News To view this content, JavaScript must be enabled, and you need the latest version of the Adobe Flash Player. Download the free Flash Player now! Highlights Alexion Recognized As One Of THE Fastest Gr more

Home | Santaris...RNA Medicines for the 21st Century

Contact  |  FAQ  |  Site Map About – Vision – Management – The Board – Pharmaceutical Partners – Investors – Business Strategy – Corporate Governance – Company FAQ – Contact LNA Drug Platform – Drug Discovery Engine – microRNA – mRNA – Publications Product Pipeline – Drug Candidates Intellectual Pro more

All websites on rare diseases

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE